NOT-HL-14-211: NHLBI Announces FAQ Page Available for RFA-HL-14-023 "Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01)"

NHLBI Announces FAQ Page Available for RFA-HL-14-023 "Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01)"

Notice Number: NOT-HL-14-211

Key Dates
Release Date: February 4, 2014

Related Announcements
RFA-HL-14-023

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to alert prospective applicants that the NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding applications for RFA-HL-14-023.

The FAQs are available on the NHLBI website at http://www.nhlbi.nih.gov/funding/inits/RFA-HL-14-023.htm. All applicants are encouraged to review the FAQs prior to submitting their application. We anticipate updating the FAQ page as needed and recommend that applicants check back for updates to the FAQ regularly until their submission date.

Interested applicants are encouraged to contact the NHLBI program official if they have questions concerning this announcement.

Inquiries

Please direct all inquiries to:

Shimian Zou, Ph.D.
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0074
Email: zousn@nhlbi.nih.gov